When a company does something that corporate-governance activists really don’t like, like adopting a poison […]
I remain fascinated by this Carl Icahn – CVR Energy situation and wanted to add […]
Corporate venture capital has begun to rival “traditional” venture capital and angel investing in its importance as an investment source for healthcare industry innovation. However, unlike VCs and angels, there is a dearth of information on how the various players in the corporate venture sector operate.
And so he’s not paying them on principle, the principle being I suppose “don’t fuck […]
Sell-side M&A work is mostly a pretty good and lucrative business model but it has a few flaws. Try to spot a key one here:
(1) you represent a target;
(2) you spend your days fighting tooth and nail with the buyer to try to make them pay more and give up optionality, and generally to get more of the benefits of the deal for the target than for the buyer;
(3) then the buyer acquires the target, fires all the directors and officers, changes the locks, and replaces the stationery;
(4) then you get paid.
Did you spot the problem? Carl Icahn did:
If you want to buy a company you can do it in one of two […]